The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

NYSE Euronext Announces Second Quarter 2013 Financial Results

<p class='bwalignc'> <i>-- Second Quarter GAAP Diluted EPS of $0.71 vs. $0.49 in Prior Year --</i> </p> <p class='bwalignc'> <i>-- Non-GAAP Diluted EPS of $0.63, Up 24% Excluding Merger Expenses, Exit Costs and Discrete Items --</i> </p> <p class='bwalignc'> <i>-- Global Leader in IPOs Year-to-Date; Share of Tech IPOs at 64% --</i> </p> <p class='bwalignc'> <i>-- Cumulative $161 Million in Project 14 Cost Savings Achieved; 64% of $250 Million Project 14 Goal --</i> </p> <p class='bwalignc'> <i>-- Significant Progress Made on the Proposed ICE Transaction --</i> </p> <p class='bwalignc'> <i>-- Clearing for London-Based Derivatives Market Transitioned to ICE Clear Europe --</i> </p> <p> <b>Financial and Operating Highlights</b><sup><b>1, 2</b></sup> </p> <ul> <li class='bwlistitemmargb'> <i>Diluted non-GAAP EPS of $0.63, up 24% compared to 2Q12; Up 11% from 1Q13</i> </li> <li class='bwlistitemmargb'> <i>Net revenue of $611 million up 1% compared to 2Q12; Up 2% from 1Q13</i> </li> <li class='bwlistitemmargb'> <i>Fixed operating expenses of $382 million, down 5% on constant dollar / portfolio basis vs. 2Q12</i> </li> <li class='bwlistitemmargb'> <i>Operating income of $229 million, up 11% compared to 2Q12; Up 4% from 1Q13</i> </li> <li class='bwlistitemmargb'> <i>Debt-to-EBITDA ratio 1.9 times, down from 2.5 times at end of 2012</i> </li> <li class='bwlistitemmargb'> <i>Board declares third quarter 2013 cash dividend of $0.30 per share provided that the ICE transaction has not been completed as of the September 16</i><sup><i>th</i></sup><i> record date.</i> </li> </ul> <p> <sup><i>1 </i></sup><i>All comparisons versus 2Q12 unless otherwise stated.</i> <i>Excludes merger expenses, exit costs, charge for fair value adjustment to RSU awards, disposal activities and discrete tax items.</i> </p> <p> <sup><i>2</i></sup><i> A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables.</i> <i>See also our statement on non-GAAP financial measures at the end of this earnings release.</i> </p>

Tuesday, July 30, 2013

NYSE Euronext Announces Second Quarter 2013 Financial Results

02:30 EDT Tuesday, July 30, 2013

NEW YORK (Business Wire) -- NYSE Euronext (NYX) today reported net income of $173 million, or $0.71 per diluted share on a GAAP basis, for the second quarter of 2013, compared to net income of $125 million, or $0.49 per diluted share, for the second quarter of 2012. Results for the second quarter of 2013 and 2012 included $22 million and $12 million, respectively, of pre-tax merger expenses and exit costs. Second quarter 2013 results also included a $10 million gain recorded for non-operating items due to the sale of a portion of our equity stake in LCH.Clearnet and a reserve release related to a favorable settlement with certain European tax authorities which significantly reduced our GAAP effective tax rate. Excluding merger expenses, exit costs, disposal activity and discrete tax items, net income in the second quarter of 2013 was $153 million, or $0.63 per diluted share on a non-GAAP basis, compared to $128 million, or $0.51 per diluted share, in the second quarter of 2012.

“We continue to execute solidly against our business plan as we build momentum toward closing the ICE deal,” said Duncan L. Niederauer, CEO, NYSE Euronext. “We successfully transitioned our London-based derivatives market to ICE Clear Europe and were ranked number one year-to-date in capital raising with our market share in technology listings increasing to 64%. The strength of our listings franchise continues to build and we are very pleased to welcome Oracle to the NYSE today to close the market. We were also appointed the administrator for LIBOR. Turning to our transaction with ICE, we are gratified that our shareholders and the European Commission have approved the transaction and we are working with the College of Regulators in Europe and other regulators to obtain all the appropriate remaining approvals.”

The table below summarizes the financial results1 for the second quarter of 2013:

                                 
            % Δ 2Q13   Year-to-Date   % Δ YTD '13
($ in millions, except EPS)       2Q13   1Q13   2Q12   vs. 2Q12   2013   2012   vs. YTD '12
Total Revenues 2 $995 $963 $986 1% $1,958   $1,938 1%
Total Revenues, Less Transaction-Based Expenses 3 611 600 602 1% 1,211 1,203 1%
Other Operating Expenses 4 382 380 396 (4%) 762 801 (5%)
Operating Income 4 $229 $220 $206 11% $449 $402 12%
Net Income 5 $153 $139 $128 20% $292 $249 17%
Diluted Earnings Per Share 5       $0.63   $0.57   $0.51   24%   $1.19   $0.97   22%
Operating Margin 37% 37% 34% 3 ppts 37% 33% 4 ppts
Adjusted EBITDA Margin       48%   47%   45%   3 ppts   47%   44%   3 ppts
 

1 A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.

2 Includes activity assessment fees.
3 Transaction-based expenses include Section 31 fees, liquidity payments and routing & clearing fees.

4 Excludes merger expenses, exit costs and charge for fair value adjustment to RSU awards.

5 Excludes merger expenses, exit costs, charge for fair value adjustment to RSU awards, disposal activities and discrete tax items.

“Our results for the second quarter reflect the actions we have taken to grow our businesses and diligently manage our cost base and capital,” commented Michael S. Geltzeiler, Group Executive Vice President and CFO, NYSE Euronext. “On a constant dollar/portfolio basis, costs are down 7% year-to-date and we have already achieved 64% of the $250 million Project 14 target for costs reductions, well ahead of the 60% promised by year-end 2013. Further cost savings will come online in the second-half of 2013 with the completed transition to ICE Clear Europe which will position us to easily surpass our full-year cost guidance target of $1,525 million. Turning to capital, capital expenditures year-to-date are running 30% below the prior year period and we are on track to come in well below our 2013 guidance of $150 million. We retired the $414 million remaining on our $750 million June 2013 notes, which combined with strong EBITDA generation, reduced our debt-to-EBITDA ratio to 1.9 times. The debt retirement will reduce interest expense in the second half of the year. All of these actions have helped bolster our business model and set the table for our proposed combination with ICE.”

SECOND QUARTER 2013 CONSOLIDATED RESULTS

Total revenues, less transaction-based expenses, which include Section 31 fees, liquidity payments and routing and clearing fees (net revenue), were $611 million in the second quarter of 2013, up 1% from the second quarter of 2012 and included a $2 million negative impact from foreign currency fluctuations.

Other operating expenses, excluding merger expenses and exit costs, were $382 million in the second quarter of 2013, down $14 million, or 4% compared to the second quarter of 2012. Excluding the impact of new business initiatives and a $2 million positive impact attributable to foreign currency fluctuations, other operating expenses were down $20 million, or 5%, compared to the second quarter of 2012.

Cumulative Project 14 savings through the second quarter of 2013 were $161 million, which represented 64% of the total $250 million expected to be saved by the end of 2014.

Operating income, excluding merger expenses and exit costs, was $229 million, up $23 million, or 11% compared to the second quarter of 2012.

Adjusted EBITDA, excluding merger expenses and exit costs, was $291 million, up $19 million, or 7% compared to the second quarter of 2012. Adjusted EBITDA margin was 48% in the second quarter of 2013, compared to 45% in the second quarter of 2012.

Loss from associates is primarily related to New York Portfolio Clearing. Net (income) loss attributable to non-controlling interest consists primarily of net income attributable to NYSE Amex Options, which was partially offset by the net loss attributable to NYSE Liffe U.S.

The effective tax rate for the second quarter of 2013, excluding merger expenses, exit costs and discrete tax items, was 24% compared to approximately 25% for the second quarter of 2012.

The weighted average diluted shares outstanding in the second quarter of 2013 was 244 million, down from 253 million in second quarter of 2012.

At June 30, 2013, total debt was $2.2 billion. The decline in total debt was driven by the retirement of the remaining $414 million of our $750 million 4.80% notes that were due in June 2013. Cash, cash equivalents and short term financial investments (including $154 million related to Section 31 fees collected from market participants and due to the SEC) were $0.3 billion and net debt was $1.9 billion.

The ratio of debt-to-EBITDA at the end of the second quarter of 2013 was 1.9x, down from 2.5x at the end of 2012. The decline was driven by the retirement of the remaining $414 million of our $750 million 4.80% notes due in June 2013 and stronger adjusted EBITDA generation in the first half of 2013, compared to the second half of 2012.

Total capital expenditures were $32 million in the second quarter of 2013, down from $41 million in the second quarter of 2012.

The board of directors declared a cash dividend of $0.30 per share for the third quarter of 2013 with a record date of September 16, 2013 and a payment date of September 30, 2013. The anticipated ex-date will be September 12, 2013. However, the third quarter 2013 dividend is payable on the payment date only if the ICE transaction has not been completed as of the record date.

SECOND QUARTER 2013 SEGMENT RESULTS

Below is a summary of business segment results:

                                         
        Derivatives   Cash Trading & Listings   Info. Svcs. & Tech. Solutions
($ in millions)       Net   Operating   Adjusted   Net   Operating   Adjusted     Operating   Adjusted
        Revenue 1   Income 2   EBITDA 2   Revenue 1   Income 2   EBITDA 2   Revenue   Income 2   EBITDA 2
2Q13 $195 $103 $111 $302 $128 $169 $114 $25 $38
1Q13 $201 $104 $113 $287 $114 $154 $112 $25 $38
2Q12       $182   $85   $95   $300   $127   $170   $119   $27   $40
YTD 2013 $396 $207 $224 $589 $242 $323 $226 $50 $76
YTD 2012       $358   $164   $184   $604   $246   $331   $240   $55   $82
 
1 Net revenue defined as total revenues less transaction-based expenses including Section 31 fees, liquidity payments and routing & clearing fees.
2 Excludes merger expenses and exit costs.

DERIVATIVES

Derivatives net revenue of $195 million in the second quarter of 2013 increased $13 million, or 7% compared to the second quarter of 2012 and included a $3 million negative impact from foreign currency fluctuations. The $16 million increase in derivatives net revenue, on a constant currency basis, compared to the second quarter of 2012, was driven by higher average daily trading volumes in European interest rate derivatives products. Highlights for the second quarter of 2013 included:

  • Global derivatives ADV, excluding Bclear, in the second quarter of 2013 of 7.7 million contracts increased 12% compared to the second quarter of 2012, but decreased 2% compared to first quarter of 2013 levels.
  • NYSE Euronext European derivatives products ADV of 4.0 million contracts in the second quarter of 2013 decreased 13% compared to the second quarter of 2012 and decreased 10% from first quarter of 2013 levels. Excluding Bclear, European derivatives products ADV in the second quarter of 2013 increased 13% compared to the second quarter of 2012, but decreased 9% from the first quarter of 2013.
  • U.S. equity options ADV in the second quarter of 2013 increased 12% to 4.4 million contracts compared to the second quarter of 2012 and increased 3% from the first quarter of 2013. U.S. consolidated equity options ADV of 15.9 million contracts increased 7% compared to the second quarter of 2012 and increased 6% from the first quarter of 2013. NYSE Euronext's U.S. equity options exchanges accounted for 28% of total consolidated U.S. equity options trading in the second quarter of 2013, up from 26% in the second quarter of 2012, and in-line with the first quarter of 2013.
  • NYSE Liffe and ICE Clear Europe, a wholly-owned subsidiary of IntercontinentalExchange, completed the clearing transition for the London-based derivatives market of NYSE Liffe to ICE Clear Europe. The clearing transition involved 43 member firms with 75 million contract sides being transferred to ICE Clear Europe along with $11.2 billion margin held at the clearing house on the morning of July 1, 2013. The combined guaranty fund for ICE Energy and NYSE Liffe Futures and Options is set at $1.2 billion from July 1, 2013. In addition, the migration covered over 1,300 products across bond, commodity, equity, index and interest rate derivatives and ten new settlement currencies for ICE Clear Europe.
  • NYSE Euronext Rate Administration Limited, a subsidiary of NYSE Euronext, announced that following a rigorous selection process conducted by the independent Hogg Tendering Advisory Committee, NYSE Euronext Rate Administration Limited has been appointed as the new administrator for LIBOR. The transfer of the administration from BBA LIBOR Ltd, the subsidiary of the British Bankers' Association is expected to be completed in early 2014, once the Financial Conduct Authority's authorization of NYSE Euronext Rate Administration Limited is complete.

CASH TRADING AND LISTINGS

Cash Trading and Listings net revenue of $302 million in the second quarter of 2013 increased $2 million, or 1% compared to the second quarter of 2012 and included a $1 million positive impact from foreign currency fluctuations. Highlights for the second quarter of 2013 included:

  • European cash ADV of 1.5 million transactions in the second quarter of 2013 decreased 14% from 1.7 million transactions in the second quarter of 2012, but increased 7% from first quarter of 2013 levels. European cash market share (value traded) in NYSE Euronext's four core markets was 67% in the second quarter of 2013, up from 66% in the second quarter of 2012 and up from 65% in the first quarter of 2013.
  • In the U.S., cash trading ADV in the second quarter of 2013 decreased 11% to 1.6 billion shares from 1.8 billion shares in the second quarter of 2012, but increased 5% from the first quarter of 2013. Tape A matched market share was 31% in the second quarter of 2013, down from the 32% recorded in the second quarter of 2012, but up from 30% recorded in the first quarter of 2013. Trading off-exchange, as reported by Trade Reporting Facilities (“TRF”), increased to 35% of overall consolidated average daily volume in the second quarter of 2013 up from 32% in the second quarter of 2012.
  • NYSE Euronext ranked #1 globally in initial public offerings (IPOs) and follow-ons globally through the second quarter of 2013. NYSE Euronext raised $29 billion in total global proceeds on 72 IPOs and $105 billion in total global proceeds on 256 follow-ons. In the U.S., NYSE Euronext led the market with 47 IPOs raising $15 billion in proceeds (excluding closed-end funds) and has steadily captured share in technology-based IPOs. NYSE Euronext has listed 64% of the technology IPOs in the U.S., through the second quarter of 2013, including Tableau Software, Gigamon, Light in the Box and ChannelAdvisor.
  • NYSE was the leader in transfers – 4 companies with $168 billion in total market capitalization transferred or announcing transfer to the NYSE in the first half of 2013, while 8 companies with $3.9 billion in total market capitalization transferred away. Oracle Corp. (ORCL) announced transfer to the NYSE on 6/20/2013, and began trading on the NYSE on 7/15/2013. ORCL is the largest transfer in history with $156 billion in market capitalization. Since 2010, five Nasdaq-100 Index members have transferred to the NYSE, including two in 2013 (Oracle Corp. and Perrigo Co.). Since 2000, 227 companies have transferred to the NYSE with a total market capitalization of $706 billion.
  • In the first half of 2013, NYSE Euronext welcomed 23 new listings on its European markets. Key listings included: Infosys (INFY), a global leader in consulting and technology and the first Indian company admitted to trading on NYSE Euronext's London and Paris markets; Constellium (CSTM), a global leader in innovative and high value‐added aluminum products; and Bpost (BPOST), the leading postal operator in Belgium, and the year's second largest IPO in Europe and the largest non-finance related IPO.
  • NYSE Euronext opened EnterNext®, its marketplace for SMEs. This new subsidiary is dedicated to companies that have a capitalization of under €1 billion and already covers over 750 SMEs listed on the regulated market of NYSE Euronext and on NYSE Alternext.
  • Euronext extended its range of stock market indices with the addition of the CAC 40® Ext, which tracks the market's benchmark CAC 40®, but with extended calculation and distribution hours. With the CAC 40® Ext index, investors can track trends in the CAC 40®.

INFORMATION SERVICES AND TECHNOLOGY SOLUTIONS

Information Services and Technology Solutions revenue was $114 million in the second quarter of 2013, a decrease of $5 million, or 4% compared to the second quarter of 2012 but increased $2 million or 2% from the first quarter of 2013. The decrease in revenue was primarily due to the decline in the number of large, one-time managed services sales which was partially offset by higher market data revenue from previously announced market data initiatives. Highlights for the second quarter of 2013 included:

  • NYSE Technologies launched NYSE BQT (Best Quote & Trades), a consolidated XDP feed that provides a real-time, unified view of Level 1 market data, including Best Bid/Offer and Last Sale information for the NYSE, NYSE Arca, and NYSE MKT exchanges including NASDAQ issues traded on NYSE Arca and NYSE MKT.
  • Market Data initiatives continue to build with approximately 84% of all clients registered for the new non-display license agreements. This momentum will be further reflected in the third quarter and on an annual basis is expected to increase revenues by double digits.
  • NYSE Technologies was named 'Best Data Center Provider to the Sell Side' by Waters Technology. The award was presented at the Waters Technology, Sell Side Technology Awards.
  • Americas Trading System Brasil (ATS Brasil), a joint venture between Americas Trading Group (ATG) and NYSE Euronext, has formally made an authorization request with the Securities and Exchange Commission (CVM) in Brazil to launch a new stock exchange in the Brazilian market. The formal request to approve ATS Brasil for trading in 2014 also includes provisions for the admission of new liquidity providers to the joint venture.

The accompanying tables include information integral to assessing the Company's financial performance.

Analyst/Investor/Media Call: July 30, 2013 at 8:00 a.m. (NY/EDT) / 2:00 p.m. (Paris/CEST)

A presentation and live audio webcast of the second quarter 2013 earnings conference call will be available on the Investor Relations section of NYSE Euronext's website, http://www.nyseeuronext.com/ir. Those wishing to listen to the live conference via telephone should dial-in at least ten minutes before the call begins. An audio replay of the conference call will be available approximately one hour after the call on the Investor Relations section of NYSE Euronext's website, http://www.nyseeuronext.com/ir or by dial-in beginning approximately two hours following the conclusion of the live call.

Live Dial-in Information:

United States: 877.280.4962

International: 857.244.7319

Passcode: 32047272

 

Replay Dial-in Information:

United States: 888.286.8010

International: 617.801.6888

Passcode: 32457864

Non-GAAP Financial Measures

To supplement NYSE Euronext's consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure, calculated and presented in accordance with GAAP. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results, but are provided to (i) present the effects of certain merger expenses, exit costs, disposal activities, the BlueNext tax settlement, debt refinancing costs, charge for fair value adjustment to RSU awards and discrete tax items, and (ii) improve overall understanding of NYSE Euronext's current financial performance and its prospects for the future. Specifically, NYSE Euronext believes the non-GAAP financial results provide useful information to both management and investors regarding certain additional financial and business trends relating to financial condition and operating results. In addition, management uses these measures for reviewing financial results and evaluating financial performance. The non-GAAP adjustments for all periods presented are based upon information and assumptions available as of the date of this release.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: http://www.nyx.com.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

This written communication contains “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “may,” “hope,” “will,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” “continue,” “could,” “future” or the negative of those terms or other words of similar meaning. You should carefully read forward-looking statements, including statements that contain these words, because they discuss our future expectations or state other “forward-looking” information. Forward-looking statements are subject to numerous assumptions, risks and uncertainties which change over time. ICE Group, ICE and NYSE Euronext caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement.

Forward-looking statements include, but are not limited to, statements about the benefits of the proposed merger involving ICE Group, ICE and NYSE Euronext, including future financial results, ICE's and NYSE Euronext's plans, objectives, expectations and intentions, the expected timing of completion of the transaction and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in ICE's and NYSE Euronext's filings with the U.S. Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, without limitation, the following: the inability to close the merger in a timely manner; the failure to satisfy other conditions to completion of the merger, including receipt of required regulatory and other approvals; the failure of the proposed transaction to close for any other reason; the possibility that any of the anticipated benefits of the proposed transaction will not be realized; the risk that integration of NYSE Euronext's operations with those of ICE will be materially delayed or will be more costly or difficult than expected; the challenges of integrating and retaining key employees; the effect of the announcement of the transaction on ICE's, NYSE Euronext's or the combined company's respective business relationships, operating results and business generally; the possibility that the anticipated synergies and cost savings of the merger will not be realized, or will not be realized within the expected time period; the possibility that the merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management's attention from ongoing business operations and opportunities; general competitive, economic, political and market conditions and fluctuations; actions taken or conditions imposed by the United States and foreign governments or regulatory authorities; and adverse outcomes of pending or threatened litigation or government investigations. In addition, you should carefully consider the risks and uncertainties and other factors that may affect future results of the combined company, as are described in the section entitled “Risk Factors” in the joint proxy statement/prospectus filed by ICE Group with the SEC, and as described in ICE's and NYSE Euronext's respective filings with the SEC that are available on the SEC's web site located at www.sec.gov, including the sections entitled “Risk Factors” in ICE's Form 10-K for the fiscal year ended December 31, 2012, as filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE Euronext's Form 10-K for the fiscal year ended December 31, 2012, as filed with the SEC on February 26, 2013. You should not place undue reliance on forward-looking statements, which speak only as of the date of this written communication. Except for any obligations to disclose material information under the Federal securities laws, ICE Group, ICE and NYSE Euronext undertake no obligation to publicly update any forward-looking statements to reflect events or circumstances after the date of this written communication.

IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE TO FIND IT

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, ICE Group has filed with the SEC a registration statement on Form S−4, which the SEC has declared effective and which contains a joint proxy statement/prospectus with respect to the proposed acquisition of NYSE Euronext by ICE Group. The final joint proxy statement/prospectus has been delivered to the stockholders of ICE and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION. Investors and security holders may obtain a free copy of the joint proxy statement/prospectus, as well as other filings containing information about ICE and NYSE Euronext, without charge, at the SEC's website at http://www.sec.gov. Investors may also obtain these documents, without charge, from ICE's website at http://www.theice.com and from NYSE Euronext's website at http://www.nyx.com.

Please follow us at:
Exchanges Blog
Facebook
LinkedIn
Twitter

             
NYSE Euronext
Condensed consolidated statements of income (unaudited)
(in millions, except per share data)
               
Three months ended Six months ended
June 30, 2013 Mar. 31, 2013 June 30, 2012 June 30, 2013 June 30, 2012
 
 
Revenues
Transaction and clearing fees $ 657 $ 634 $ 649 $ 1,291 $ 1,258
Market data 91 83 87 174 178
Listing 111 110 112 221 222
Technology services 77 80 87 157 173
Other revenues   59     56     51     115     107  
Total revenues 995 963 986 1,958 1,938
Transaction-based expenses:
Section 31 fees 78 75 86 153 152
Liquidity payments, routing and clearing   306     288     298     594     583  
Total revenues, less transaction-based expenses   611     600     602     1,211     1,203  
Other operating expenses
Compensation 154 161 152 315 312
Depreciation and amortization 62 62 66 124 132
Systems and communications 42 43 44 85 89
Professional services 67 69 69 136 142
Selling, general and administrative 57 55 65 112 126
Merger expenses and exit costs   22     8     12     30     43  
Total other operating expenses   404     398     408     802     844  
 
Operating income 207 202 194 409 359
Net interest and investment income (loss) (25 ) (27 ) (28 ) (52 ) (56 )
Loss from associates (3 ) (2 ) (2 ) (5 ) (3 )
Net gain (loss) on disposal activities 10 - (2 ) 10 (2 )
Other income (loss)   6     (1 )   3     5     3  
Income before income taxes 195 172 165 367 301
Income tax (provision) benefit   (17 )   (41 )   (34 )   (58 )   (79 )
Net income 178 131 131 309 222
Net (income) loss attributable to noncontrolling interest   (5 )   (5 )   (6 )   (10 )   (10 )
Net income attributable to NYSE Euronext $ 173   $ 126   $ 125   $ 299   $ 212  
 
Basic earnings per share attributable to NYSE Euronext $ 0.71 $ 0.52 $ 0.50 $ 1.23 $ 0.83
 
Diluted earnings per share attributable to NYSE Euronext $ 0.71 $ 0.52 $ 0.49 $ 1.22 $ 0.83
 
Basic weighted average shares outstanding 243 243 252 243 255
Diluted weighted average shares outstanding   244       244       253     244       256  
 
 

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 
Three months ended Six months ended

Non-GAAP Reconciliation

June 30, 2013

Mar. 31, 2013 June 30, 2012 June 30, 2013 June 30, 2012
 
Income (loss) before income taxes - GAAP $ 195 $ 172 $ 165 $ 367 $ 301
Excluding:
Merger expenses and exit costs 22 8 12 30 43
Net (gain) loss on disposal activities (10 ) - 2 (10 ) 2
Fair value adjustment to RSU awards   -     10     -     10     -  
Income before income taxes - as adjusted 207 190 179 397 346
Income tax provision   (49 )   (46 )   (45 )   (95 )   (87 )
Net income - as adjusted 158 144 134 302 259
Net (income) loss attributable to noncontrolling interest   (5 )   (5 )   (6 )   (10 )   (10 )
Net income attributable to NYSE Euronext - as adjusted $ 153   $ 139   $ 128   $ 292   $ 249  
 
Diluted earnings per share attributable to NYSE Euronext $ 0.63   $ 0.57   $ 0.51   $ 1.19   $ 0.97  
 
                         
NYSE Euronext
Segment Results (unaudited)
(in millions)
                                   
Three months ended Three months ended
June 30, 2013 June 30, 2012
Derivatives

Cash Trading
and Listings

Information
Services and
Technology
Solutions

Corporate
and
Eliminations

Consolidated Derivatives

Cash
Trading and
Listings

Information
Services and
Technology
Solutions

Corporate and
Eliminations

Consolidated
 
Revenues
Transaction and clearing fees $ 262 $ 395 $ - $ - $ 657 $ 219 $ 430 $ - $ - $ 649
Market data 10 44 37 - 91 11 44 32 - 87
Listing - 111 - - 111 - 112 - - 112
Technology services - - 77 - 77 - - 87 - 87
Other revenues   13     46     -     -     59     10     40     -     1     51  
Total revenues 285 596 114 - 995 240 626 119 1 986
Transaction-based expenses:
Section 31 fees - 78 - - 78 - 86 - - 86
Liquidity payments, routing and clearing   90     216     -     -     306     58     240     -     -     298  
Total revenues, less transaction-based expenses 195 302 114 - 611 182 300 119 1 602
Depreciation and amortization [a] 8 41 13 - 62 10 43 13 - 66
Merger expenses and exit costs (M&E) [b] 3 3 1 15 22 7 7 4 (6 ) 12
Other operating expenses   84     133     76     27     320     87     130     79     34     330  
Operating income - GAAP [c] $ 100   $ 125   $ 24   $ (42 ) $ 207   $ 78   $ 120   $ 23   $ (27 ) $ 194  
Operating income excluding M&E [c] + [b] $ 103   $ 128   $ 25   $ (27 ) $ 229   $ 85   $ 127   $ 27     (33 ) $ 206  
Adjusted EBITDA [c] + [b] + [a] $ 111     $ 169     $ 38     $ (27 )   $ 291   $ 95     $ 170     $ 40       (33 )   $ 272  
 
Operating margin excluding M&E 53 % 42 % 22 % N/M 37 % 47 % 42 % 23 % N/M 34 %
Adjusted EBITDA margin 57 % 56 % 33 % N/M 48 % 52 % 57 % 34 % N/M 45 %
 
                                   
Six months ended Six months ended
June 30, 2013 June 30, 2012
Derivatives

Cash Trading
and Listings

Information
Services and
Technology
Solutions

Corporate
and
Eliminations

Consolidated Derivatives

Cash
Trading and
Listings

Information
Services and
Technology
Solutions

Corporate and
Eliminations

Consolidated
 
Revenues
Transaction and clearing fees $ 533 $ 758 $ - $ - $ 1,291 $ 425 $ 833 $ - $ - $ 1,258
Market data 20 85 69 - 174 22 89 67 - 178
Listing - 221 - - 221 - 222 - - 222
Technology services - - 157 - 157 - - 173 - 173
Other revenues   25     90     -     -     115     22     84     -     1     107  
Total revenues 578 1,154 226 - 1,958 469 1,228 240 1 1,938
Transaction-based expenses:
Section 31 fees - 153 - - 153 - 152 - - 152
Liquidity payments, routing and clearing   182     412     -     -     594     111     472     -     -     583  
Total revenues, less transaction-based expenses 396 589 226 - 1,211 358 604 240 1 1,203
Depreciation and amortization [a] 17 81 26 - 124 20 85 27 - 132
Merger expenses and exit costs (M&E) [b] 5 7 4 14 30 8 13 10 12 43
Fair value adjustment to RSU awards [c] - - - 10 10 - - - - -
Other operating expenses   172     266     150     50     638     174     273     158     64     669  
Operating income - GAAP [d] $ 202   $ 235   $ 46   $ (74 ) $ 409   $ 156   $ 233   $ 45   $ (75 ) $ 359  
Operating income excluding M&E and fair

value adjustment to RSU awards

[d] + [c] + [b] $ 207   $ 242   $ 50   $ (50 ) $ 449   $ 164   $ 246   $ 55   $ (63 ) $ 402  
Adjusted EBITDA [d] + [c] + [b] + [a] $ 224     $ 323     $ 76     $ (50 )   $ 573   $ 184     $ 331     $ 82     $ (63 )   $ 534  
 
Operating margin excluding M&E and fair

value adjustment to RSU awards

52 % 41 % 22 % N/M 37 % 46 % 41 % 23 % N/M 33 %
Adjusted EBITDA margin 57 % 55 % 34 % N/M 47 % 51 % 55 % 34 % N/M 44 %

 

 

 

 

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our
GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

N/M = Not meaningful

 
             
NYSE Euronext
Fixed operating expenses (unaudited)
(in millions)
   

Expense Base Development on a Constant $ / Constant Portfolio Basis

 
Fixed operating expenses for the three months ended June 30, 2013 - GAAP $ 404
Less:
Merger expenses and exit costs   (22 )
$ 382
Excluding the impact of:
Currency translation 2
New business initiatives (8 )
 
Fixed operating expenses for the three months ended June 30, 2013 - as adjusted $ 376   [a]
 
Fixed operating expenses for the three months ended June 30, 2012 - GAAP $ 408
Less:
Merger expenses and exit costs   (12 )
Fixed operating expenses for the three months ended June 30, 2012 - as adjusted $ 396   [b]
 
Variance ($) $ (20 ) [a] - [b] = [c]
Variance (%)   -5 % [c] / [b]
 
Fixed operating expenses for the six months ended June 30, 2013 - GAAP $ 802
Less:
Fair value adjustment to RSU awards $ (10 )
Merger expenses and exit costs   (30 )
$ 762
Excluding the impact of:
Currency translation 3
New business initiatives (17 )
 
Fixed operating expenses for the six months ended June 30, 2013 - as adjusted $ 748   [a]
 
Fixed operating expenses for the six months ended June 30, 2012 - GAAP $ 844
Less:
Merger expenses and exit costs   (43 )
Fixed operating expenses for the six months ended June 30, 2012 - as adjusted $ 801   [b]
 
Variance ($) $ (53 ) [a] - [b] = [c]
Variance (%)   -7 % [c] / [b]
 
 

Expense Base Development Versus Project 14 Cost Savings Plan

 
 
Fixed operating expenses for the six months ended June 30, 2013 - GAAP $ 802
Fixed operating expenses for the six months ended December 31, 2012 - GAAP   871  
Fixed operating expenses for the trailing twelve months ended June 30, 2013 - GAAP $ 1,673
Less:
Fair value adjustment to RSU awards $ (13 )
Merger expenses and exit costs   (121 )
$ 1,539
Excluding the impact of:
New business initiatives (52 )
Currency translation(1)   18  

Fixed operating expenses for the trailing twelve months ended June 30, 2013 - as adjusted

$ 1,505   [a]
 
Fixed operating expenses for the year ended December 31, 2011 - base year $ 1,666   [b]
 
 
Project 14 Cost Savings $ 161   [b]-[a] = [c]
 
Cumulative Project 14 Cost Savings to date as % of total $250 million plan   64 % [c] / $250
 
 
(1) We measure the Project 14 cost savings utilizing constant currency rates of $1.35 for the Euro and $1.60 for the Pound Sterling.
 
 

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of
our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

       
NYSE Euronext
Condensed consolidated statements of financial condition (unaudited)
(in millions)
 
June 30, Dec. 31,
  2013   2012
 
Assets
Current assets:
Cash, cash equivalents, and short term financial investments $ 322 $ 380
Accounts receivable, net 442 405
Deferred income taxes 65 67
Other current assets   119   156
Total current assets 948 1,008
 
Property and equipment, net 887 948
Goodwill 4,027 4,163
Other intangible assets, net 5,573 5,783
Deferred income taxes 70 74
Other assets   541   580
Total assets $ 12,046 $ 12,556
 
Liabilities and equity
Accounts payable and accrued expenses $ 727 $ 824
Deferred revenue 314 138
Short term debt   179   454
Total current liabilities 1,220 1,416
 
Long term debt 2,039 2,055
Deferred income taxes 1,401 1,435
Accrued employee benefits 562 602
Deferred revenue 375 378
Other liabilities   22   27
Total liabilities   5,619   5,913
 
Redeemable noncontrolling interest   286   274
 

Equity

6,141

6,369
   
Total liabilities and equity $ 12,046 $ 12,556
 
                                   

NYSE Euronext

Selected Statistical Data:

Volume Summary

 
Average Daily Volume

 

Total Volume Total Volume
(Unaudited) 2Q13 1Q13

% ∆ 2Q13
vs. 1Q13

2Q12

% ∆ 2Q13
vs. 2Q12

2Q13 1Q13

% ∆ 2Q13
vs. 1Q13

2Q12

% ∆ 2Q13
vs. 2Q12

 

 

YTD 2013 YTD 2012

 

% ∆

 
Number of Trading Days - European Cash 63 62 62 63 62 62 125 127

 

Number of Trading Days - European Derivatives 64 62 63 64 65 63 126 128

 

Number of Trading Days - U.S. Markets 64 60 63 64 60 63 124 125

 

                                                               
European Derivatives Products (contracts in thousands)         4,048       4,515     -10.3 %     4,654     -13.0 %       259,087       279,936     -7.4 %     293,182     -11.6 %       539,024     509,777     5.7 %

 

of which Bclear 749 883 -15.2 % 1,743 -57.1 % 47,918 54,749 -12.5 % 109,827 -56.4 % 102,666 153,556 -33.1 %
Avg. Net Revenue Per Contract (ex. Bclear) $ 0.610 $ 0.622 -1.9 % $ 0.674 -9.5 % $ 0.610 $ 0.622 -1.9 % $ 0.674 -9.5 %
Avg. Net Revenue Per Contract (ex. Bclear) - Currency Neutral $ 0.610 $ 0.618 -1.3 % $ 0.656 -7.0 % $ 0.610 $ 0.618 -1.3 % $ 0.656 -7.0 %
                                                               
Total Interest Rate Products 1         2,463       2,749     -10.4 %     1,953     26.1 %       157,654       170,433     -7.5 %     123,059     28.1 %       328,087     238,387     37.6 %
 
Short Term Interest Rate Products 2,276 2,560 -11.1 % 1,801 26.4 % 145,688 158,710 -8.2 % 113,479 28.4 % 304,398 218,917 39.0 %

 

Medium and Long Term Interest Rate Products 187 189 -1.1 % 152 22.9 % 11,965 11,723 2.1 % 9,580 24.9 % 23,689 19,469 21.7 %

 

                                                               
Total Equity Products 2         1,496       1,674     -10.7 %     2,622     -43.0 %       95,732       103,802     -7.8 %     165,188     -42.0 %       199,534     261,162     -23.6 %
 
Individual Equity Products 966 1,132 -14.7 % 2,065 -53.2 % 61,801 70,179 -11.9 % 130,086 -52.5 % 131,980 196,328 -32.8 %

 

Futures 606 660 -8.2 % 1,603 -62.2 % 38,806 40,948 -5.2 % 100,962 -61.6 % 79,755 134,137 -40.5 %

 

Options 359 471 -23.8 % 462 -22.3 % 22,995 29,231 -21.3 % 29,124 -21.0 % 52,226 62,191 -16.0 %

 

Equity Index Products 530 542 -2.2 % 557 -4.8 % 33,931 33,623 0.9 % 35,102 -3.3 % 67,554 64,834 4.2 %

 

 
of which Bclear 748 881 -15.1 % 1,743 -57.1 % 47,918 54,749 -12.5 % 109,827 -56.4 % 102,666 153,556 -33.1 %

 

Individual Equity Products 650 758 -14.2 % 1,667 -61.0 % 41,625 47,008 -11.5 % 105,025 -60.4 % 88,633 144,023 -38.5 %

 

Futures 579 649 -10.9 % 1,561 -62.9 % 37,032 40,267 -8.0 % 98,312 -62.3 % 77,299 130,972 -41.0 %

 

Options 72 109 -34.0 % 107 -32.7 % 4,593 6,742 -31.9 % 6,713 -31.6 % 11,334 13,051 -13.2 %

 

Equity Index Products 98 123 -20.5 % 76 28.4 % 6,262 7,630 -17.9 % 4,801 30.4 % 13,892 9,533 45.7 %

 

                                                               
Commodity Products         89       92     -3.1 %     78     13.7 %       5,701       5,701     0.0 %     4,935     15.5 %       11,403     10,228     11.5 %

 

                                                               
U.S. Derivatives Products (contracts in thousands)                                                              
Avg. Net Revenue Per Contract (ex. Liffe U.S. volumes) $ 0.156 $ 0.150 4.0 % $ 0.150 4.0 % $ 0.156 $ 0.150 4.0 % $ 0.150 4.0 %
 
Equity Options Contracts3 4,376 4,231 3.4 % 3,915 11.8 % 280,070 253,843 10.3 % 246,634 13.6 % 533,914 502,556 6.2 %

 

Total Consolidated Options Contracts 15,879 14,981 6.0 % 14,911 6.5 % 1,016,261 898,885 13.1 % 939,423 8.2 % 1,915,146 1,923,930 3.9 %

 

 
Share of Total Consolidated Options Contracts 27.6 % 28.2 % 26.3 % 27.6 % 28.2 % 26.3 % 27.9 % 26.1 % 1.8 %

 

                                                               
NYSE Liffe U.S.                                                              
 
Futures and Futures Options Volume* 63.3 58.7 7.7 % 73.4 -13.8 % 4,111.7 3,641.1 12.9 % 4,769.3 -13.8 % 7,752.8 10,930.6 -29.1 %

 

                                                               
European Cash Products (trades in thousands)         1,470       1,378     6.7 %     1,709     -14.0 %       92,600       85,419     8.4 %     105,934     -12.6 %       178,020     208,861     -14.8 %
Avg. Net Revenue Per Transaction $ 0.562 $ 0.620 -9.4 % $ 0.519 8.3 % $ 0.562 $ 0.620 -9.4 % $ 0.519 8.3 %
Avg. Net Revenue Per Transaction - Currency Neutral $ 0.562 $ 0.616 -8.8 % $ 0.530 6.0 % $ 0.562 $ 0.616 -8.8 % $ 0.530 6.0 %
 
Equities 1,418 1,326 7.0 % 1,656 -14.4 % 89,352 82,199 8.7 % 102,668 -13.0 % 171,551 202,107 -15.1 %

 

Exchange-Traded Funds 15 14 8.1 % 14 3.1 % 932 848 9.9 % 890 4.8 % 1,780 1,831 -2.8 %

 

Structured Products 32 33 -2.0 % 33 -3.9 % 2,011 2,019 -0.4 % 2,059 -2.3 % 4,030 4,294 -6.2 %

 

Bonds 5 6 -14.9 % 5 -5.2 % 305 353 -13.5 % 317 -3.7 % 658 628 4.9 %

 

                                                               
U.S. Cash Products (shares in millions)         1,626       1,545     5.2 %     1,823     -10.8 %       104,043       92,721     12.2 %     114,863     -9.4 %       196,764     225,100     -12.6 %
Avg. Net Revenue Per 100 Shares Handled $ 0.0473 $ 0.0431 9.7 % $ 0.0428 10.5 % $ 0.0473 $ 0.0431 9.7 % $ 0.0428 10.5 %
                                                               
NYSE Listed (Tape A) Issues 4                                                              
 
Handled Volume 5 1,154 1,120 3.0 % 1,304 -11.5 % 73,870 67,207 9.9 % 82,157 -10.1 % 141,077 161,180 -12.5 %

 

Matched Volume 6 1,113 1,077 3.4 % 1,239 -10.2 % 71,262 64,603 10.3 % 78,081 -8.7 % 135,865 152,613 -11.0 %

 

Total NYSE Listed Consolidated Volume 3,608 3,585 0.6 % 3,885 -7.1 % 230,911 215,111 7.3 % 244,756 -5.7 % 446,022 488,556 -8.7 %

 

 
Share of Total Consolidated Volume
Handled Volume 5 32.0 % 31.2 % 33.6 % 32.0 % 31.2 % 33.6 % 31.6 % 33.0 %

 

Matched Volume 6 30.9 % 30.0 % 31.9 % 30.9 % 30.0 % 31.9 % 30.5 % 31.2 %

 

                                                               
NYSE Arca, MKT and Regional (Tape B) Listed Issues                                                              
 
Handled Volume 5 286 224 27.4 % 279 2.4 % 18,298 13,466 35.9 % 17,582 4.1 % 31,764 34,023 -6.6 %

 

Matched Volume 6 263 207 26.8 % 251 4.6 % 16,823 12,435 35.3 % 15,826 6.3 % 29,258 30,497 -4.1 %

 

Total NYSE Arca & NYSE MKT Listed Consolidated Volume 1,248 994 25.4 % 1,188 5.0 % 79,841 59,667 33.8 % 74,843 6.7 % 139,508 144,466 -3.4 %

 

 
Share of Total NYSE Arca & NYSE MKT Listed Consolidated Volume
Handled Volume 5 22.9 % 22.6 % 23.5 % 22.9 % 22.6 % 23.5 % 22.8 % 23.6 %

 

Matched Volume 6 21.1 % 20.8 % 21.1 % 21.1 % 20.8 % 21.1 % 21.0 % 21.1 %

 

                                                               
Nasdaq Listed Issues (Tape C)                                                              
 
Handled Volume 5 186 201 -7.6 % 240 -22.7 % 11,875 12,048 -1.4 % 15,123 -21.5 % 23,923 30,218 -20.8 %

 

Matched Volume 6 166 179 -7.5 % 206 -19.3 % 10,610 10,758 -1.4 % 12,950 -18.1 % 21,368 25,726 -16.9 %

 

Total Nasdaq Listed Consolidated Volume 1,781 1,822 -2.3 % 1,802 -1.2 % 113,979 109,316 4.3 % 113,554 0.4 % 223,295 224,885 -0.7 %

 

 
Share of Total Nasdaq Listed Consolidated Volume
Handled Volume 5 10.4 % 11.0 % 13.3 % 10.4 % 11.0 % 13.3 % 10.7 % 13.4 %

 

Matched Volume 6 9.3 % 9.8 % 11.4 % 9.3 % 9.8 % 11.4 % 9.6 % 11.4 %

 

                                                               
Exchange-Traded Funds 5,7                                                              
 
Handled Volume 5 267 212 25.9 % 265 0.8 % 17,094 12,733 34.2 % 16,693 2.4 % 29,827 32,100 -7.1 %

 

Matched Volume 6 245 196 25.1 % 238 3.0 % 15,694 11,761 33.4 % 14,995 4.7 % 27,455 28,714 -4.4 %

 

Total ETF Consolidated Volume 1,203 959 25.5 % 1,167 3.2 % 77,019 57,554 33.8 % 73,495 4.8 % 134,573 140,693 -4.3 %

 

 
Share of Total ETF Consolidated Volume
Handled Volume 5 22.2 % 22.1 % 22.7 % 22.2 % 22.1 % 22.7 % 22.2 % 22.8 %

 

Matched Volume 6 20.4 % 20.4 % 20.4 % 20.4 % 20.4 % 20.4 % 20.4 % 20.4 %

 

 

1

  Data includes currency products.
2 Includes trading activities for Bclear, NYSE Liffe's service for Equity OTC derivatives.
3 Includes trading in U.S. equity options contracts, not equity-index options.
4 Includes all volume executed in NYSE Euronext's U.S. crossing sessions.
5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Euronext's U.S. exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Euronext's U.S. exchanges.
7 Data included in previously identified categories.
* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.
         
NYSE Euronext

Selected Statistical Data:

Other Operating Statistics

 
Three Months Ended
(Unaudited) June 30, 2013 Mar. 31, 2013 June 30, 2012
                 
NYSE Euronext Listed Issuers                
                 
NYSE Listed Issuers                
 
Issuers listed on U.S. Markets1 2,942 2,928 2,968
Number of new issuer listings1 88 46 75
Capital raised in connection with new listings ($millions)2 $8,982 $5,746 $5,086
                 
Euronext Listed Issuers                
 
Issuers listed on Euronext1 884 884 923
Number of new issuer listings3 14 10 10
Capital raised in connection with new listings ($millions)2 $1,207 $6 $1,912
 
                 
NYSE Euronext Market Data                
                 
NYSE Market Data 4                
 
Share of Tape A revenues (%) 40.3% 39.5% 41.4%
Share of Tape B revenues (%) 26.7% 26.6% 27.0%
Share of Tape C revenues (%) 13.5% 13.6% 15.1%
Professional subscribers (Tape A) 331,102 333,430 360,121
                 
Euronext Market Data                
 
Number of terminals 202,389 205,764 216,752
 
                 
NYSE Euronext Operating Expenses                
                 
NYSE Euronext employee headcount                
 
NYSE Euronext headcount5 3,154 3,171 3,062
 
                 
NYSE Euronext Financial Statistics                
                 
NYSE Euronext foreign exchange rate                
 
Average €/US$ exchange rate $1.306 $1.320 $1.254
Average £/US$ exchange rate $1.536 $1.552 $1.583
 
1   Figures for NYSE listed issuers include listed operating companies, special-purpose acquisition companies and closed-end funds listed on the NYSE and NYSE MKT and do not include NYSE Arca or structured products listed on the NYSE. There were 1,385 ETPs exclusively listed on NYSE Arca as of June 30, 2013. There were 413 corporate structured products listed on the NYSE as of June 30, 2013.

Figures for new issuer listings include NYSE new listings (including new operating companies, special-purpose acquisition companies and closed-end funds listing on NYSE) and new ETP listings on NYSE Arca (NYSE MKT is excluded). Figures for Euronext present the operating companies were listed on Euronext and do not include NYSE Alternext, Free Market, closed-end funds, ETFs and structured product (warrants and certificates). As of June 30, 2013, 181 companies were listed on NYSE Alternext, 252 on Free Market and 673 ETPs were listed on NextTrack.

 
2 Euronext figures show capital raised in millions of dollars by operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (warrants and certificates). NYSE figures show capital raised in millions of dollars by operating companies listed on NYSE and NYSE Arca and do not include closed-end funds, ETFs and structured products.
 
3 Euronext figures include operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (warrants and certificates).
 
4 "Tape A" represents NYSE listed securities, "Tape B" represents NYSE Arca and NYSE MKT listed securities, and "Tape C" represents Nasdaq listed securities. Per Regulation NMS, as of April 1, 2007, share of revenues is derived through a formula based on 25% share of trading, 25% share of value traded, and 50% share of quoting, as reported to the consolidated tape. Prior to April 1, 2007, share of revenues for Tape A and B was derived based on number of trades reported to the consolidated tape, and share of revenue for Tape C was derived based on an average of share of trades and share of volume reported to the consolidated tape. The consolidated tape refers to the collection and dissemination of market data that multiple markets make available on a consolidated basis. Share figures exclude transactions reported to the FINRA/NYSE Trade Reporting Facility.
 
5 Headcount as of March 31, 2013 included 120 employees from the insourcing of offshore resources as part of the January 2013 creation of NYSE Philippines.
 
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

Media:
Amsterdam, +31.20.550.4488
Lisbon, +351.217.900.029
New York, +1-212-656-2411
or
Brussels, +32.2.509.1392
London, +44.20.7379.2789
Paris, +33.1.49.27.11.33
or
Investor Relations:
New York, +1-212-656-5700

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections